MonoRab™
11 Weeks from Antigen to Antibody – High-quality, Speed, and Reliability Delivered
Receive your quote directly from the manufacturer.
GenScript's custom rabbit monoclonal antibody development service offers high specificity and affinity monoclonal antibodies featuring industry-leading turnaround time—just 11 weeks from immunogen preparation to purified antibodies. Through its novel MonoRab™ B-cell cloning platform and Beacon® single B cell screening platform, GenScript is able to deliver the most clones for in-house application screening .
MonoRab™ is a full-scale service which combines GenScript’s expertise in peptide generation, molecular biology, recombinant protein expression, and antibody discovery. Through GenScript’s novel antibody generation technology, MonoRab™ is able to produce large scales of recombinant antibodies while maintaining native antibody chains at a highly competitive price.
Tailored antigen design for high-specificity, high-affinity mAbs
Accelerate therapeutic antibody discovery and development with MonoRab™, the newly upgraded premier rabbit mAb service from GenScript, for custom-made antibodies specific to your application. In this video, Dr. Samantha Zaroff explains how the technology generates a large number of high-quality rabbit monoclonal antibodies for any application, with a stress-free workflow that aims to ensure delivery of the maximum number of clones for application-based testing.
A high-throughput test for neutralizing antibodies to SARS-CoV-2 as alternative to live virus neutralization and immunoglobulin detection
Join this webinar to find out how scientists are detecting the antibodies blocking viral entry into the cell
Video highlights from Neuroscience 2019
Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago
GenScript upgrades MonoRab™, its premier rabbit mAb generation platform
MonoRab™; superior antibody generation with a stress-free workflow that ensures delivery of the most clones for application-based testing, 10 different mAb variable chain sequences, and expert level recombinant antibody expression
